Migden, Michael, John Lear, Nicholas Squittieri, Li Liu, Alexander Guminski, and Reinhard Dummer. “Duration of Response and Progression-Free Survival With Sonidegib 200 Mg Once Daily Until Disease Progression or Start of New Antineoplastic Therapy in Patients With Locally Advanced Basal Cell Carcinoma: Results of the 42-Month, Randomized, Double-Blind”. SKIN The Journal of Cutaneous Medicine 4, no. 5 (September 2, 2020): s68. Accessed July 5, 2022. https://www.jofskin.org/index.php/skin/article/view/1017.